KOVÁŘOVÁ, Lucie, M. AL-SAHMANI, Jana ŠTOSSOVÁ, Tamara VARMUŽOVÁ, Pavla ZARBOCHOVÁ, Ivana BUREŠOVÁ, Muthu Raja MUTHU RAJA, Henrieta GREŠLIKOVÁ, Pavel NĚMEC, Renata KUPSKÁ, Petr KUGLÍK, Miroslav PENKA and Roman HÁJEK. Plasma cell phenotype correlation with cytogenetic and morphological findings in multiple myeloma. In 13th International Myeloma Workshop. 2011. ISSN 0390-6078.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Plasma cell phenotype correlation with cytogenetic and morphological findings in multiple myeloma
Authors KOVÁŘOVÁ, Lucie, M. AL-SAHMANI, Jana ŠTOSSOVÁ, Tamara VARMUŽOVÁ, Pavla ZARBOCHOVÁ, Ivana BUREŠOVÁ, Muthu Raja MUTHU RAJA, Henrieta GREŠLIKOVÁ, Pavel NĚMEC, Renata KUPSKÁ, Petr KUGLÍK, Miroslav PENKA and Roman HÁJEK.
Edition 13th International Myeloma Workshop, 2011.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.424
Organization unit Faculty of Medicine
ISSN 0390-6078
Keywords in English Plasma cells; phenotype; multiple myeloma
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 21/6/2011 10:51.
Abstract
Plasma cells (PCs) phenotype could correlate with presence of genetic abnormalities and/or morphological subtypes thus could be related to patient’s prognosis as well. The aim of work was to find relation between antigenic profile, cytogenetic aberrations and morphology in MM patients. Analyses were done in 134 newly diagnosed MM patients. Bone marrow PCs were analysed for expression of CD19, CD20, CD27, CD28, CD56 and CD117 by immunophenotyping. FISH on separated PCs was used for analysis of del(13)(q14), del(17)(p13), IGH disruption, t(4;14)(p16.3;q32), 1q21 gain and hyperdiploidy. PC subtypes evaluation was based on the nucleus/cytoplasm (N/C) ratio. Clonal CD19+ PCs were found in 1 patient with del(13)(q14). CD56+ PCs were found in 79.1% (106/134) and correlated with lower expression of CD20 and CD28. CD56+ PCs were more immature than CD56- PCs. CD20+ PCs were found in 8.2% (11/134) and correlated with higher expression of CD28, CD117 and lower expression of CD56. CD27 was less expressed in group with higher number of CD56+ PCs and CD27+ PCs were more mature. CD28 was expressed in 24.6% (33/134). CD28- PCs were more immature than CD28+ PCs. CD117+ PCs was found in 31.3% (42/134)and significantly correlated with hyperdiploidy, negativity for CD117 was associated with del(13)(q14). Result showed CD117 as the only marker corresponding to chromosomal abnormalities. According to morphology assessment majority of PCs was more mature type.
Links
GAP304/10/1395, research and development projectName: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
GP301/09/P457, research and development projectName: Uplatnění multiparametrické průtokové cytometrie ve studiu patofyziologie maligních plazmatických buněk
Investor: Czech Science Foundation
LC06027, research and development projectName: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
NS10207, research and development projectName: Úloha abnormalit chromozómu 1 a kaskády NF-kappaB v patogenezi mnohočetného myelomu
Investor: Ministry of Health of the CR
NS10406, research and development projectName: Vytvoření prognostického panelu u pacientů s monoklonální gamapatií nejasného významu s cílem zabránění transformace v maligní onemocnění.
Investor: Ministry of Health of the CR
NS10408, research and development projectName: Fenotypový profil B lymfocytů a plazmatických buněk a jeho souvislost s maligní transformací u monoklonálních gamapatií
PrintDisplayed: 4/5/2024 16:01